Laboratory of Preclinical Pharmacology National Institute of Mental Health, Saint Elizabeths Hospital, 20032, Washington D.C..
Neurochem Res. 1976 Apr;1(2):217-27. doi: 10.1007/BF00966112.
The endogenous phosphodiesterase activator (PDEA) described by Cheung (1,2) is, in part, stored as a membrane-bound protein (12,13). PDEA can be released from the membranes by a cAMP-dependent phosphorylation of a protein that may function as PDEA binding site (13). We found that PDEA can be released from brain particulate fraction by 1 μM norepinephrine, dopamine, adenosine, and histamine in the presence of ATP and a purified cAMP-dependent protein kinase; in similar conditions, serotonin is ineffective in concentrations up to 0.1 mM. Norepinephrine and dopamine activate the adenylate cyclase activity of those preparations from which they release the PDEA. Norepinephrine is more potent than dopamine in releasing PDEA from the particulate fraction of cerebellum, whereas dopamine is more active than norepinephrine in releasing PDEA from the particulate fraction of striatum. The release of PDEA elicited by both neurotransmitters is concentration-dependent; increasing the transmitter concentrations above a certain limit decreases the rate of PDEA release.
张(1、2)所描述的内源性磷酸二酯酶激活剂(PDEA)部分以膜结合蛋白的形式储存(12、13)。PDEA 可以通过可能作为 PDEA 结合位点的蛋白的 cAMP 依赖性磷酸化从膜上释放(13)。我们发现,在 ATP 和纯化的 cAMP 依赖性蛋白激酶存在的情况下,1μM 的去甲肾上腺素、多巴胺、腺苷和组氨酸可以从脑颗粒部分释放 PDEA;在类似的条件下,血清素在高达 0.1mM 的浓度下无效。去甲肾上腺素和多巴胺激活了从它们释放 PDEA 的那些制剂的腺苷酸环化酶活性。去甲肾上腺素比多巴胺更能从小脑颗粒部分释放 PDEA,而多巴胺比去甲肾上腺素更能从纹状体颗粒部分释放 PDEA。这两种神经递质引起的 PDEA 释放都是浓度依赖性的;将递质浓度提高到一定限度以上会降低 PDEA 释放的速度。